亨通光電(600487.SH):中標15.09億元海洋能源項目
格隆匯7月24日丨亨通光電(600487.SH)公佈,公司及控股子公司陸續收到項目《中標通知書》或簽署項目合同,確認中標國內外海洋能源項目,中標總金額爲15.09億元。公司緊抓海洋產業發展機遇,持續在能源互聯領域爲客戶創造價值,不斷提升海洋能源產業鏈系統解決方案整體實力。多年以來,公司聚焦全球風電資源,持續中標國內外海上風電和海洋油氣項目體現了公司在海洋能源領域的綜合技術實力,有利於進一步提升和鞏固公司在全球海洋能源領域的品牌影響力。近期累計中標、簽署合同金額約15.09億元,佔公司2024年度經審計營業收入的2.52%,該批項目合同的履行預計將對公司未來經營業績產生一定積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.